SWK Holdings ( (SWKH) ) has provided an announcement.
The Company has published an investor presentation showcasing their use of Non-GAAP Financial Measures to provide a clearer picture of operations alongside traditional GAAP results. This approach aims to help investors better assess shareholder value. The company operates through two main segments, Life Science Specialty Finance and Enteris BioPharma, focusing on monetizing revenue streams and intellectual property. By offering secured financing solutions and maintaining minimal leverage, the Company targets high returns and increased book value per share, appealing to investors interested in the financial markets.
For an in-depth examination of SWKH stock, go to TipRanks’ Stock Analysis page.
